Sintayehu Admas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sintayehu Admas has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Arega Zenaw
Department of Clinical Chemistry, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences University of Gondar Gondar Ethiopia
2 shared publications Bisrat Birke Teketelew
Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences University of Gondar Gondar Ethiopia
2 shared publicationsLyusira Marelgn
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences Mizan Tepi University Mizan Aman Ethiopia
2 shared publicationsNigusie Alemu
Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences University of Gondar Gondar Ethiopia
2 shared publicationsYemataw Gelaw
Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences University of Gondar Gondar Ethiopia
2 shared publicationsAbebe Birhanu
Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences University of Gondar Gondar Ethiopia
1 shared publication
Latest Publications
- Open Access
- 26 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (9) , e73144
Serum Albumin and Uric Acid Levels Among Hypertensive Patients in Northwest Ethiopia: A Comparative Cross‐Sectional Study
Background and Aims: Hypertension is a long‐term condition marked by consistently high arterial blood pressure. Hypertensive patients often experience altered serum albumin and uric acid, attributed to factors like inflammation, kidney damage, and the activation of the renin angiotensin aldosterone system. However, localized evidence regarding these biomarkers remains scarce within the Ethiopian context. This study aimed to assess the level of serum albumin and uric acid among hypertensive patients. Methods: A comparative cross‐sectional study was conducted from March 1 to May 30, 2025, involving 232 study participants selected using systematic random sampling. Of these, 116 were patients with hypertensive and 116 were normotensives. Sociodemographic, behavioral, and clinical data were measured by structured questionnaires. Serum albumin and uric acid levels were measured by spectrophotometric principle. Data were analyzed using SPSS version 25 software. Descriptive statistics, independent t ‐tests, and binary logistic regression were performed with significance set at p < 0.05. Results: The mean age of the study participants was 46 ± 11.4 and 45 ± 11.6 for the case and control groups. There was a statistically significant difference in mean serum albumin and uric acid levels between the case and control groups. The prevalence of hypoalbuminemia and hyperuricemia among hypertensive patients were 25.9% (95% CI: 18.2%, 34.8%) and 23.3% (95% CI: 15.9%, 32%), respectively. Multivariable logistic regression showed hypertensive patients with albuminuria had 3.3 and 16.1 odds of developing hypoalbuminemia and hyperuricemia. Conclusion: This study demonstrates that the prevalence of hypoalbuminemia and hyperuricemia was higher in hypertensive patients than the controls. Albuminuria was a significant predictor of hypoalbuminemia and hyperuricemia. This underscores the potential metabolic alterations that may be associated with hypertension. Thus, it is important to monitor these parameters in hypertensive individuals.
- 26 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (9) , e73144
Open AccessSerum Albumin and Uric Acid Levels Among Hypertensive Patients in Northwest Ethiopia: A Comparative Cross‐Sectional Study
Background and Aims: Hypertension is a long‐term condition marked by consistently high arterial blood pressure. Hypertensive patients often experience altered serum albumin and uric acid, attributed to factors like inflammation, kidney damage, and the activation of the renin angiotensin aldosterone system. However, localized evidence regarding these biomarkers remains scarce within the Ethiopian context. This study aimed to assess the level of serum albumin and uric acid among hypertensive patients. Methods: A comparative cross‐sectional study was conducted from March 1 to May 30, 2025, involving 232 study participants selected using systematic random sampling. Of these, 116 were patients with hypertensive and 116 were normotensives. Sociodemographic, behavioral, and clinical data were measured by structured questionnaires. Serum albumin and uric acid levels were measured by spectrophotometric principle. Data were analyzed using SPSS version 25 software. Descriptive statistics, independent t ‐tests, and binary logistic regression were performed with significance set at p < 0.05. Results: The mean age of the study participants was 46 ± 11.4 and 45 ± 11.6 for the case and control groups. There was a statistically significant difference in mean serum albumin and uric acid levels between the case and control groups. The prevalence of hypoalbuminemia and hyperuricemia among hypertensive patients were 25.9% (95% CI: 18.2%, 34.8%) and 23.3% (95% CI: 15.9%, 32%), respectively. Multivariable logistic regression showed hypertensive patients with albuminuria had 3.3 and 16.1 odds of developing hypoalbuminemia and hyperuricemia. Conclusion: This study demonstrates that the prevalence of hypoalbuminemia and hyperuricemia was higher in hypertensive patients than the controls. Albuminuria was a significant predictor of hypoalbuminemia and hyperuricemia. This underscores the potential metabolic alterations that may be associated with hypertension. Thus, it is important to monitor these parameters in hypertensive individuals.
- Open Access
- 25 May 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (6) , e72562
Diagnostic Accuracy of Inflammatory Biomarkers in Differentiating Acute Appendicitis From Other Acute Abdomen and Predicting Disease Severity: A Prospective Comparative Cross‐Sectional Study
Introduction: Acute appendicitis (AA) is one of the most common clinical conditions for emergency surgery. The diagnosis of acute appendicitis remains challenging for surgeons. Researchers are still looking for a parameter that is less expensive and easily available for diagnosis. The main aim of the study was to determine the diagnostic accuracy of inflammatory biomarkers for AA and the severity of inflammation. Methods: A prospective comparative cross‐sectional study was conducted among 161 participants (80 with acute appendicitis and 81 non‐AA abdominal pain controls) recruited using a consecutive sampling technique. The study was conducted from August 21, 2024 to January 16, 2025. In this study, we have investigated the diagnostic utility of white blood cells (WBC), neutrophil to lymphocyte ratio (NLR), systemic inflammatory index (SII) and systemic inflammation response index (SIRI) for AA. Normality was assessed using the Shapiro–Wilk test and visual inspections. Mean differences for WBC were compared using the Independent sample t ‐test, while the Mann–Whitney U test was employed for others. ROC curve analysis was done for statistically significant parameters ( p value < 0.05 with 95%CI). Post‐hoc power analysis was performed using G*Power 3.1.9.7 to ensure study robustness. Result: Males account for 57.76% of participants. The mean age of non‐AA and AA group was 26.47 ± 8.53 and 24.34 ± 9.77 years, respectively. The AA group demonstrated significantly higher WBC, NLR, SII and SIRI levels compared to non‐AA. Significantly higher WBC, NLR, SII and SIRI levels were observed in complicated AA (CAA) groups relative to simple AA (SAA) groups. The area under the ROC curve (AUC) of WBC, NLR, SII, and SIRI to diagnose AA was 0.814, 0.834, 0.816, and 0.814, respectively. WBC, NLR, SII, and SIRI can predict CAA with AUC of 0.722, 0.781, 0.770, and 0.715, respectively. Conclusion: Inflammatory markers, including WBC, NLR, SII, and SIRI have acceptable diagnostic performance for AA. Additionally, WBC, NLR, SII and SIRI possess potential for differentiating CAA from SAA. It may be better for surgeons to consider the level of NLR, SII and SIRI for the diagnosis of AA and to determine its severity. However, further studies on a larger sample size are recommended to validate their clinical utility.
- 25 May 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (6) , e72562
Open AccessDiagnostic Accuracy of Inflammatory Biomarkers in Differentiating Acute Appendicitis From Other Acute Abdomen and Predicting Disease Severity: A Prospective Comparative Cross‐Sectional Study
Introduction: Acute appendicitis (AA) is one of the most common clinical conditions for emergency surgery. The diagnosis of acute appendicitis remains challenging for surgeons. Researchers are still looking for a parameter that is less expensive and easily available for diagnosis. The main aim of the study was to determine the diagnostic accuracy of inflammatory biomarkers for AA and the severity of inflammation. Methods: A prospective comparative cross‐sectional study was conducted among 161 participants (80 with acute appendicitis and 81 non‐AA abdominal pain controls) recruited using a consecutive sampling technique. The study was conducted from August 21, 2024 to January 16, 2025. In this study, we have investigated the diagnostic utility of white blood cells (WBC), neutrophil to lymphocyte ratio (NLR), systemic inflammatory index (SII) and systemic inflammation response index (SIRI) for AA. Normality was assessed using the Shapiro–Wilk test and visual inspections. Mean differences for WBC were compared using the Independent sample t ‐test, while the Mann–Whitney U test was employed for others. ROC curve analysis was done for statistically significant parameters ( p value < 0.05 with 95%CI). Post‐hoc power analysis was performed using G*Power 3.1.9.7 to ensure study robustness. Result: Males account for 57.76% of participants. The mean age of non‐AA and AA group was 26.47 ± 8.53 and 24.34 ± 9.77 years, respectively. The AA group demonstrated significantly higher WBC, NLR, SII and SIRI levels compared to non‐AA. Significantly higher WBC, NLR, SII and SIRI levels were observed in complicated AA (CAA) groups relative to simple AA (SAA) groups. The area under the ROC curve (AUC) of WBC, NLR, SII, and SIRI to diagnose AA was 0.814, 0.834, 0.816, and 0.814, respectively. WBC, NLR, SII, and SIRI can predict CAA with AUC of 0.722, 0.781, 0.770, and 0.715, respectively. Conclusion: Inflammatory markers, including WBC, NLR, SII, and SIRI have acceptable diagnostic performance for AA. Additionally, WBC, NLR, SII and SIRI possess potential for differentiating CAA from SAA. It may be better for surgeons to consider the level of NLR, SII and SIRI for the diagnosis of AA and to determine its severity. However, further studies on a larger sample size are recommended to validate their clinical utility.
- Open Access
- 19 February 2026
- Published by SAGE Publications in Therapeutic Advances in Hematology
- Vol. 17
The role of antioxidants in multiple myeloma: diagnostic, prognostic, and therapeutic applications: a narrative review
Multiple myeloma (MM) is a B-cell malignancy involving monoclonal plasma cells that produce nonfunctional immunoglobulins. It is still incurable due to de novo or acquired resistance of malignant cells to standard chemotherapies. Thus, understanding the mechanism of therapeutic resistance is essential to develop better interventions and identifying new therapeutic targets. MM is a heterogeneous disease characterized by complex genetic alterations, which are critical for prognostic stratification. Due to the heterogeneity and clinical challenges associated with MM, there remains a critical need for novel biomarkers to improve both early diagnosis and prognostic accuracy. Antioxidants participate in protecting cancer cells from the damaging effects of oxidative stress by neutralizing reactive oxygen species. These molecules may have their own role in myeloma progression and drug resistance. However, studies reported contradictory ideas regarding the levels and roles of antioxidants in MM. The main aim of this review is to conceptualize the diagnostic, prognostic, and therapeutic significance of common antioxidants for MM. The most common antioxidant systems discussed in this study were DJ-1, glutathione, thioredoxin, and superoxide dismutase. The review revealed that antioxidants are overexpressed in myeloma cells compared to normal plasma cells. This excess expression of antioxidants increases tumor cells’ survival and their chemoresistance leads to poor prognosis and short survival of myeloma patients. Thus, antioxidants and their synthesis pathways may have a promising prognostic, diagnostic, and therapeutic role in MM. Vitamin C (ascorbic acid), on the other hand, has a two-faced role in cancer, including MM. It can function as an antioxidant (increase myeloma cell resistance to chemotherapy) or pro-oxidant (enhance the therapeutic effect of myeloma drugs), depending on its dose and route of administration. Pharmacological (ultra-high) doses of vitamin C administered intravenously may act as a pro-oxidant that can selectively kill myeloma cells by elevating the cellular labile iron pool and generating extracellular H 2 O 2 .
- 19 February 2026
- Published by SAGE Publications in Therapeutic Advances in Hematology
- Vol. 17
Open AccessThe role of antioxidants in multiple myeloma: diagnostic, prognostic, and therapeutic applications: a narrative review
Multiple myeloma (MM) is a B-cell malignancy involving monoclonal plasma cells that produce nonfunctional immunoglobulins. It is still incurable due to de novo or acquired resistance of malignant cells to standard chemotherapies. Thus, understanding the mechanism of therapeutic resistance is essential to develop better interventions and identifying new therapeutic targets. MM is a heterogeneous disease characterized by complex genetic alterations, which are critical for prognostic stratification. Due to the heterogeneity and clinical challenges associated with MM, there remains a critical need for novel biomarkers to improve both early diagnosis and prognostic accuracy. Antioxidants participate in protecting cancer cells from the damaging effects of oxidative stress by neutralizing reactive oxygen species. These molecules may have their own role in myeloma progression and drug resistance. However, studies reported contradictory ideas regarding the levels and roles of antioxidants in MM. The main aim of this review is to conceptualize the diagnostic, prognostic, and therapeutic significance of common antioxidants for MM. The most common antioxidant systems discussed in this study were DJ-1, glutathione, thioredoxin, and superoxide dismutase. The review revealed that antioxidants are overexpressed in myeloma cells compared to normal plasma cells. This excess expression of antioxidants increases tumor cells’ survival and their chemoresistance leads to poor prognosis and short survival of myeloma patients. Thus, antioxidants and their synthesis pathways may have a promising prognostic, diagnostic, and therapeutic role in MM. Vitamin C (ascorbic acid), on the other hand, has a two-faced role in cancer, including MM. It can function as an antioxidant (increase myeloma cell resistance to chemotherapy) or pro-oxidant (enhance the therapeutic effect of myeloma drugs), depending on its dose and route of administration. Pharmacological (ultra-high) doses of vitamin C administered intravenously may act as a pro-oxidant that can selectively kill myeloma cells by elevating the cellular labile iron pool and generating extracellular H 2 O 2 .